Asia Pacific Bovine Lactoferrin Market Size, Share & Trends Analysis Report By Application (Infant Formula, Dietary Supplements, Pharmaceutical, and Others), By Product Type (Freeze-dried and Spray-dried), By Function, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Bovine Lactoferrin Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 152.8 Tonnes, showcasing a growth of 9.5% (2019-2022).

Bovine lactoferrin's antimicrobial and anti-inflammatory properties make it a valuable ingredient in cosmetic and dermatological formulations. It is used in skincare products such as creams, lotions, and serums to address issues like acne and promote skin health. The compound's ability to support wound healing also contributes to its inclusion in certain skincare applications. Bovine lactoferrin's strong antimicrobial properties make it suitable for various applications beyond supplements and foods. It is utilized in medical settings for wound care products and developing antimicrobial coatings for surfaces and medical devices. Its importance in these applications is further enhanced by its capacity to impede the growth of bacteria, viruses, and fungi.

Bovine lactoferrin's involvement in promoting gut health and its potential to modulate the gut microbiota has led to its inclusion in gastrointestinal health products. These products, which can be capsules or functional foods, target conditions such as inflammatory bowel diseases and support digestive well-being. Bovine lactoferrin is also utilized in the agricultural sector, particularly in animal feed and veterinary products. Its immunomodulatory effects contribute to the health and well-being of livestock, promoting disease resistance and overall animal health.

The expanding nutraceutical industry in the Asia Pacific region is a significant driver for the increased use of bovine lactoferrin. Growing disposable incomes in the Asia Pacific region allow consumers to invest in premium and health-enhancing products. Bovine lactoferrin's immunomodulatory properties make it a potential candidate as a vaccine adjuvant in Asia Pacific. Therefore, due to the above-mentioned factors, the bovine lactoferrin market will grow significantly in this region.

The China market dominated the Asia Pacific Bovine Lactoferrin Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $75,746.2 Thousands by 2030. The Japan market is registering a CAGR of 8.2% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.5% during (2023 - 2030).

Based on Application, the market is segmented into Infant Formula, Dietary Supplements, Pharmaceutical, and Others. Based on Product Type, the market is segmented into Freeze-dried and Spray-dried. Based on Function, the market is segmented into Iron Absorption, Antibacterial, Immune Cell Stimulation and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• Royal FrieslandCampina N.V.
• Fonterra Co-operative Group Limited
• Saputo, Inc.
• Glanbia PLC
• Noumi Limited
• Synlait Milk Limited
• MILEI GmbH (Morinaga Milk Industry Co., Ltd.)
• Bega Cheese Limited
• Beston Global Food Company Limited
• Savencia SA

Market Report Segmentation

By Application (Volume, Tonnes, USD Million, 2019-2030)

• Infant Formula
• Dietary Supplements
• Pharmaceutical
• Others

By Product Type (Volume, Tonnes, USD Million, 2019-2030)

• Freeze-dried
• Spray-dried.

By Function (Volume, Tonnes, USD Million, 2019-2030)

• Iron Absorption
• Antibacterial
• Immune Cell Stimulation
• Others

By Country (Volume, Tonnes, USD Million, 2019-2030)

• China
• Japan
• India
• South Korea
• Australia
• Malaysia
• Rest of Asia Pacific